Sugen falls as casualty of Pfizer-Pharmacia merger

被引：2

|

作者：

Garber, K

机构：

来源：

NATURE BIOTECHNOLOGY | 2003年 / 21卷 / 07期

关键词：

D O I：

10.1038/nbt0703-722

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：722 / 723

页数：2

相关论文

共 50 条

[31] Pfizer并购Pharmacia后重组研发部门
范淑敏
精细与专用化学品, 2003, (18) : 28 - 28
[32] Pfizer Viagra appeals falls flat
不详
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (03) : 174 - 174
[33] Warner-Lambert and Pfizer in merger tussle
不详
DIABETES OBESITY & METABOLISM, 2000, 2 (01): : 61 - 61
[34] Merger with AstraZeneca will create a scientific "powerhouse," says Pfizer
O'Dowd, Adrian
BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
[35] Tax rules kill Pfizer-Allergan merger
Thayer, Ann
CHEMICAL & ENGINEERING NEWS, 2016, 94 (15) : 3 - 3
[36] Pfizer and Allergan agree $160bn merger deal
Kmietowicz, Zosia
BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
[37] Pfizer breaks from merger mentality as others chase leads
Janelle Weaver
Nature Medicine, 2011, 17 : 761 - 761
[38] EC okays Pfizer/Warner-Lambert merger with provisos
不详
CHEMICAL & ENGINEERING NEWS, 2000, 78 (23) : 19 - 19
[39] What does Pfizer's merger mean for drug development?
Mullard, Asher
LANCET, 2016, 387 (10013): : 14 - 15
[40] Pfizer breaks from merger mentality as others chase leads
Weaver, Janelle
NATURE MEDICINE, 2011, 17 (07) : 761 - 761

← 1 2 3 4 5 →